Posted in | News | Nanomaterials | Nanobusiness

Technology Leader in Advanced Nanoengineered Products Announces Changes in Directors and Principal Officers

Nanophase Technologies (Nasdaq: NANX), a technology leader in nanomaterials and advanced nanoengineered products, announced today that the Company accepted the resignation of Dr. Richard Brotzman, effective February 28th, as its Chief Technology Officer, so that he may pursue new entrepreneurial business opportunities. Dr. Brotzman was responsible for several of the Company's key patents and served as technical liaison to many of the Company's market partners, helping to bring Nanophase from a development stage company to a commercial enterprise.

The Company also accepted the resignation of Robert Haines, VP of Operations, effective February 28, 2009, who left the Company for health related reasons. Mr. Haines was the critical driver in the Company’s progression towards developing the world-class quality-driven volume manufacturing platform that has become one of its key strengths.

Nanophase also announced that Jess Jankowski has been elevated to the position of President & Chief Executive Officer and board director, effective February 28, 2009. Mr. Jankowski had been Nanophase’s Acting Chief Executive Officer since August of 2008. He will continue to serve also as Chief Financial Officer as the Company conducts a search for his replacement in that role. Don Perkins, the Company’s Chairman, commented that “Mr. Jankowski has earned the Board’s trust over the years and has impressed us with his vision for Nanophase and the team he has developed since he assumed leadership six months ago. It is reassuring to note that Mr. Jankowski and his team hold an average of 8 years experience with Nanophase.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.